BOVIE MEDICAL CORPORATION REPORTS SECOND QUARTER 2018 FINANCIAL RESULTSBy ApyxMedical|2025-12-12T19:54:21+00:00August 1, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2018 FINANCIAL RESULTS ON AUGUST 1, 2018By ApyxMedical|2025-12-12T19:54:44+00:00July 23, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES AGREEMENT TO SELL “CORE” BUSINESS SEGMENT TO SYMMETRY SURGICAL, INC. FOR TOTAL CASH CONSIDERATION OF $97 MILLIONBy ApyxMedical|2025-12-12T19:55:07+00:00July 9, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES PRELIMINARY SECOND QUARTER 2018 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:55:40+00:00July 9, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES 2018 LIFE SCIENCE CONFERENCEBy ApyxMedical|2025-12-12T19:56:04+00:00May 31, 2018|2018 Shareholder News, J-Plasma|
Bovie Medical Corporation Reports First Quarter 2018 Financial Results; Reaffirms Fiscal Year 2018 Financial OutlookBy ApyxMedical|2025-12-12T19:56:28+00:00May 14, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES COMPLETION OF ENROLLMENT IN J-PLASMA® RENUVION™ DERMAL RESURFACING STUDYBy ApyxMedical|2025-12-12T19:56:54+00:00May 14, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF DIANE I. DUNCAN, M.D., FACS TO MEDICAL ADVISORY BOARDBy ApyxMedical|2025-12-12T19:57:17+00:00May 1, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2018 FINANCIAL RESULTS ON MAY 14, 2018By ApyxMedical|2025-12-12T19:57:38+00:00April 27, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES LAUNCH OF RENUVION™: A NEW BRAND DEDICATED TO THE COSMETIC SURGERY MARKETBy ApyxMedical|2025-12-12T19:58:00+00:00March 29, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF SCOTT R. SANDERS AS DIRECTOR OF CLINICAL EDUCATION AND MARKET DEVELOPMENTBy ApyxMedical|2025-12-12T19:58:21+00:00March 27, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF CRAIG A. SWANDAL TO BOARD OF DIRECTORSBy ApyxMedical|2025-12-12T19:58:42+00:00March 12, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS; PROVIDES FISCAL YEAR 2018 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T19:59:06+00:00March 12, 2018|2018 Shareholder News, J-Plasma|
Bovie Medical Corporation Announces Appointment of Dr. Topaz J. Kirlew as Director of Regulatory AffairsBy ApyxMedical|2025-12-12T19:59:29+00:00March 6, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2017 FINANCIAL RESULTS ON MARCH 12, 2018By ApyxMedical|2025-12-12T19:59:56+00:00February 12, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES ENROLLMENT OF FIRST PATIENT IN J-PLASMA® DERMAL RESURFACING CLINICAL STUDYBy ApyxMedical|2025-12-12T20:00:17+00:00January 23, 2018|2018 Shareholder News, J-Plasma|
